Ultrasound Genetic Medicine Platform Advances Toward Clinic

Summary SonoThera closed an oversubscribed $125M Series B financing to advance DMD and ADPKD programs toward the clinic, validating its non-viral genetic medicine delivery platform. What Happened Vida Ventures led the round with participation from ARK Invest, Otsuka, UCB Ventures, Vivo Capital, Leaps by Bayer…